Open Access

Where PCSK9 inhibitors can make a difference

Presentation

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

3 more presentations in this session

Introduction - Treatment of ischemic heart disease patients in 2018

Speaker: Professor U. Landmesser (Berlin, DE)

Thumbnail

What approach to CV risk management in 2018?

Speaker: Professor K. Ray (London, GB)

Thumbnail

Panel discussion and wrap-up - LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Speaker: Professor U. Landmesser (Berlin, DE) Doctor C. Ballantyne (Houston, US) Professor K. Ray (London, GB)

Thumbnail

Access the full session

LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Speakers: Doctor C. Ballantyne, Professor U. Landmesser, Professor K. Ray, Professor U. Landmesser, Doctor C. Ballantyne...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC Premium Access

Will coronary atherosclerosis be eliminated?

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk